Resilient Together for Dementia
The proposed study will establish the feasibility, acceptability and credibility of a novel
live video dyadic resiliency intervention, Resilient Together for Dementia (RT-D), aimed at
preventing chronic emotional distress and preserving quality of life among dyads a...
Age: 65 years - 66+
Gender: All
Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2
Aim 2 will investigate the effect of 3 different light exposure lengths on sleep, mood and
agitation in persons with Alzheimer's disease. Participants will be randomly assigned to one
of three conditions of light exposure: 1) 2-h morning light exposure; 2) 4-h morni...
Age: 65 years - 66+
Gender: All
Palliative Care for Patients with Dementia
A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the
effectiveness of a novel model of in-home palliative care for dementia patients and their
family caregivers. From inpatient and outpatient settings associated with four hospitals
acro...
Age: 65 years - 66+
Gender: All
Trial of Parkinson's and Zoledronic Acid
This home-based study is a randomized (1:1) placebo-controlled trial of a single infusion
of zoledronic acid-5 mg (ZA) for the prevention of fractures in men and women aged 60
years and older with Parkinson's disease and parkinsonism with at least 2 years of
follow-u...
Age: 60 years - 66+
Gender: All
An Efficacy and Safety Study of JNJ-54861911 in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
The purpose of this study is to evaluate whether treatment with JNJ-54861911 slows cognitive
decline compared with placebo treatment, as measured by a composite cognitive measure, the
Preclinical Alzheimer Cognitive Composite (PACC), in amyloid-positive participants w...
Age: 60 - 85 years
Gender: All